Controlling new drugs under marketing regulations [For debate]

B. HUGHES, Auteur ; A. R. WINSTOCK, Auteur ; K. KRAJEWSKI, Auteur du commentaire ; J. SHERIDAN, Auteur du commentaire ; B. ATMORE, Auteur du commentaire ; B. RUSSELL, Auteur du commentaire ; P. REUTER, Auteur du commentaire ; T. P. FREEMAN, Auteur du commentaire ; H. V. CURRAN, Auteur du commentaire | 2012
Dans Addiction (Vol.107, n°11, November 2012) Article : Périodique

Aims: The rapid emergence of myriad substances openly marketed as ‘legal highs’ is straining traditional drug control systems which require time and basic scientific data on harms to react, presenting governments with the dilemma of no response [...]

Plus d'info

Ajouter à la sélection

Lien externe

Extended-release methylphenidate for treatment of amphetamine/methamphetamine dependence: a randomized, double-blind, placebo-controlled trial

S. W. MILES ; J. SHERIDAN ; B. RUSSELL ; R. KYDD ; A. WHEELER ; C. WALTERS ; G. GAMBLE ; P. HARDLEY ; M. JENSEN ; K. KUOPPASALMI ; P. TUOMOLA ; J. FÖHR ; O. KUIKANMAKI ; H. VORMA ; R. K. SALOKANGAS ; A. MIKKONEN ; M. KALLIO ; J. KAUHANEN ; V. KIVINIEMI ; J. TIIHONEN | 2013
Dans Addiction (Vol.108, n°7, July 2013) Article : Périodique

Aims To assess the efficacy of methylphenidate as a substitution therapy for amphetamine/methamphetamine dependence in Finland and New Zealand. Design Parallel-group, double-blind, randomized placebo-controlled trial. Setting Out-patient care. P[...]

Plus d'info

Ajouter à la sélection

Lien externe

Legal piperazine-containing party pills-a new trend in substance misuse

J. SHERIDAN ; R. BUTLER ; C. WILKINS ; B. RUSSELL | 2007
Dans Drug and Alcohol Review (Vol.26 n°3, 2007) Article : Périodique

ENGLISH : In this Harm Reduction Digest Sheridan, Butler, Wilkins and Russell address the emergent phenomenon of so-called 'legal party pills' which have become a significant drug issue in New Zealand and elsewhere. Although banned in a number[...]

Plus d'info

Ajouter à la sélection

The new psychoactive substances regime in New Zealand: a different approach to regulation

C. WILKINS ; J. SHERIDAN ; P. ADAMS ; B. RUSSELL ; S. RAM ; D. NEWCOMBE | 2013
Dans Journal of Psychopharmacology (Vol.27, n°7, July 2013) Article : Périodique

The New Zealand government has proposed a new psychoactive substances regime, which will place the onus onto manufacturers to prove that their products pose a low risk of harm, prior to receiving approval which allows the products to be legally [...]

Plus d'info

Ajouter à la sélection